We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$59.9B
AUM Growth
+$1.73B
Cap. Flow
-$2.83B
Cap. Flow %
-4.72%
Top 10 Hldgs %
22.6%
Holding
1,630
New
205
Increased
595
Reduced
546
Closed
207

Top Buys

Rank Stock Value
1
BAM icon
Brookfield Asset Management
BAM
+$150M
2
FSV icon
FirstService
FSV
+$96.1M
3
TU icon
Telus
TU
+$94.5M
4
NOC icon
Northrop Grumman
NOC
+$86.8M
5
MCK icon
McKesson
MCK
+$68.1M

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$661M
2
ACN icon
Accenture
ACN
+$611M
3
LIN icon
Linde
LIN
+$338M
4
ALC icon
Alcon
ALC
+$254M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$205M

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 15.31%
3 Industrials 12.68%
4 Healthcare 10.67%
5 Energy 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSD
1376
DELISTED
Clearside Biomedical
CLSD
$37.3K ﹤0.01%
2,218
-411
-16% -$7.4K
BKD icon
1377
Brookdale Senior Living
BKD
$3.49B
$32.4K ﹤0.01%
11,859
OPK icon
1378
Opko Health
OPK
$985M
$32.3K ﹤0.01%
25,843
LU icon
1379
Lufax Holding
LU
$1.35B
$30.8K ﹤0.01%
+3,973
New +$30.3K
NUTX
1380
Nutex Health
NUTX
$1.01B
$30.4K ﹤0.01%
+107
New +$20.6K
SHCR
1381
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$30.3K ﹤0.01%
+18,951
New +$35.1K
BHIL
1382
DELISTED
Benson Hill, Inc.
BHIL
$29.8K ﹤0.01%
334
NVTA
1383
DELISTED
Invitae Corporation
NVTA
$28.6K ﹤0.01%
15,402
BNGO icon
1384
Bionano Genomics
BNGO
$12.3M
$28.3K ﹤0.01%
32
CTEV
1385
Claritev Corp
CTEV
$387M
$28.1K ﹤0.01%
612
KEEL
1386
Keel Infrastructure Corp
KEEL
$2.4B
$27.6K ﹤0.01%
66,893
+4,828
+8% +$3.56K
NKTR icon
1387
Nektar Therapeutics
NKTR
$2.39B
$27K ﹤0.01%
796
MVIS icon
1388
Microvision
MVIS
$6.21M
$25.7K ﹤0.01%
10,917
SLGC
1389
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$25.6K ﹤0.01%
10,200
ME
1390
DELISTED
23andMe Holding Co
ME
$25.5K ﹤0.01%
589
SENS icon
1391
Senseonics Holdings Inc
SENS
$263M
$25.4K ﹤0.01%
1,233
+165
+15% +$3.81K
CTMX icon
1392
CytomX Therapeutics
CTMX
$675M
$25K ﹤0.01%
15,639
SMRT icon
1393
SmartRent
SMRT
$195M
$24.7K ﹤0.01%
10,149
-3,800
-27% -$9.4K
CLOV icon
1394
Clover Health Investments
CLOV
$2.2B
$22.9K ﹤0.01%
24,649
GEVO icon
1395
Gevo
GEVO
$360M
$22.9K ﹤0.01%
12,034
INO icon
1396
Inovio Pharmaceuticals
INO
$55.7M
$22.7K ﹤0.01%
1,212
SRNE
1397
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$22.3K ﹤0.01%
25,219
YARW
1398
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$20.2K ﹤0.01%
150
AMRS
1399
DELISTED
Amyris Inc.
AMRS
$20.1K ﹤0.01%
13,145
FUBO icon
1400
FuboTV Inc
FUBO
$261M
$20.1K ﹤0.01%
963

Similar funds

Mackenzie Financial's Q4 2022 Portfolio in Review

As of Q4 2022, Mackenzie Financial held 1,630 positions worth $59.9B, up 3% from $58.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial withdrew a net $2.83B in Q4 2022, closing 207 positions and reducing 546 holdings. Its most notable exit was Aon, an estimated $661M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, Mackenzie Financial opened a new position in Brookfield Asset Management worth $142M.

  • Mackenzie Financial's largest Q4 2022 buy was Brookfield Asset Management: 4,971,865 shares worth $142M.
  • Mackenzie Financial added most to FirstService in Q4 2022, an estimated $96.1M increase.
  • Mackenzie Financial's biggest Q4 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $205M.
  • Mackenzie Financial fully exited Aon in Q4 2022, selling an estimated $661M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $59.9B portfolio in Q4 2022.
  • Mackenzie Financial opened 205 new positions and closed 207 in Q4 2022.
  • Mackenzie Financial's portfolio value rose 3% quarter-over-quarter to $59.9B.

Based on Mackenzie Financial's 13F filing for Q4 2022, filed 14 Feb 2023.